Anat Ohali

439 total citations
11 papers, 304 citations indexed

About

Anat Ohali is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Anat Ohali has authored 11 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Physiology. Recurrent topics in Anat Ohali's work include Telomeres, Telomerase, and Senescence (5 papers), Sarcoma Diagnosis and Treatment (4 papers) and Molecular Biology Techniques and Applications (2 papers). Anat Ohali is often cited by papers focused on Telomeres, Telomerase, and Senescence (5 papers), Sarcoma Diagnosis and Treatment (4 papers) and Molecular Biology Techniques and Applications (2 papers). Anat Ohali collaborates with scholars based in Israel, United States and Germany. Anat Ohali's co-authors include Isaac Yaniv, Smadar Avigad, Rina Zaizov, Ian J. Cohen, Isaac Meller, Yehuda Kollender, Yacov Goshen, Shifra Ash, Josephine Issakov and Meora Feinmesser and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Anat Ohali

11 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anat Ohali Israel 10 157 130 84 52 49 11 304
Young-Hyuck Im South Korea 5 220 1.4× 188 1.4× 80 1.0× 168 3.2× 66 1.3× 7 425
Takakazu Yokoyama Japan 10 209 1.3× 52 0.4× 96 1.1× 69 1.3× 81 1.7× 17 466
Tatsuya Ishibe Japan 12 190 1.2× 151 1.2× 16 0.2× 105 2.0× 73 1.5× 22 444
Magne Skårn Norway 9 221 1.4× 69 0.5× 29 0.3× 49 0.9× 152 3.1× 11 354
Cameron G. Binnie United States 10 96 0.6× 174 1.3× 36 0.4× 61 1.2× 60 1.2× 13 412
Anju Karki United States 9 179 1.1× 49 0.4× 32 0.4× 103 2.0× 81 1.7× 13 332
Hiroto Niizeki Japan 5 229 1.5× 55 0.4× 29 0.3× 117 2.3× 281 5.7× 12 433
Ralph Klose Germany 9 126 0.8× 41 0.3× 26 0.3× 107 2.1× 54 1.1× 11 364
Andreas Domen Belgium 9 85 0.5× 99 0.8× 45 0.5× 106 2.0× 33 0.7× 15 271
Masayuki Komatsu Japan 9 162 1.0× 107 0.8× 12 0.1× 112 2.2× 79 1.6× 19 339

Countries citing papers authored by Anat Ohali

Since Specialization
Citations

This map shows the geographic impact of Anat Ohali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Ohali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Ohali more than expected).

Fields of papers citing papers by Anat Ohali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anat Ohali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Ohali. The network helps show where Anat Ohali may publish in the future.

Co-authorship network of co-authors of Anat Ohali

This figure shows the co-authorship network connecting the top 25 collaborators of Anat Ohali. A scholar is included among the top collaborators of Anat Ohali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anat Ohali. Anat Ohali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Shichrur, Keren, Helen Toledano, Anat Ohali, et al.. (2017). Prognostic relevance of miR‐124‐3p and its target TP53INP1 in pediatric ependymoma. Genes Chromosomes and Cancer. 56(8). 639–650. 15 indexed citations
2.
Lee, Namhoon, Shankar S. Iyer, Jie Mu, et al.. (2010). Three Novel Downstream Promoter Elements Regulate MHC Class I Promoter Activity in Mammalian Cells. PLoS ONE. 5(12). e15278–e15278. 13 indexed citations
3.
Ohali, Anat, et al.. (2008). Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma. Genes Chromosomes and Cancer. 47(11). 965–970. 12 indexed citations
4.
Avigad, Smadar, Anat Ohali, Marta Jeison, et al.. (2007). Short Telomeres: A Novel Potential Predictor of Relapse in Ewing Sarcoma. Clinical Cancer Research. 13(19). 5777–5783. 29 indexed citations
5.
Ohali, Anat, Smadar Avigad, Shifra Ash, et al.. (2006). Telomere length is a prognostic factor in neuroblastoma. Cancer. 107(6). 1391–1399. 64 indexed citations
6.
Ohali, Anat, Smadar Avigad, Ian J. Cohen, et al.. (2005). The clinical relevance of telomerase activity and telomere length in pediatric solid tumors. Journal of Clinical Oncology. 23(16_suppl). 8547–8547. 1 indexed citations
7.
Ohali, Anat, Smadar Avigad, Rina Zaizov, et al.. (2004). Prediction of high risk Ewing's sarcoma by gene expression profiling. Oncogene. 23(55). 8997–9006. 81 indexed citations
8.
Ohali, Anat, Smadar Avigad, Ian J. Cohen, et al.. (2004). High frequency of genomic instability in Ewing family of tumors. Cancer Genetics and Cytogenetics. 150(1). 50–56. 19 indexed citations
9.
Amiel, Aliza, Anat Ohali, Moshe Fejgin, et al.. (2003). Molecular cytogenetic parameters in Ewing sarcoma. Cancer Genetics and Cytogenetics. 140(2). 107–112. 21 indexed citations
10.
Ohali, Anat, Smadar Avigad, Ian J. Cohen, et al.. (2003). Association Between Telomerase Activity and Outcome in Patients With Nonmetastatic Ewing Family of Tumors. Journal of Clinical Oncology. 21(20). 3836–3843. 33 indexed citations
11.
Ohali, Anat, et al.. (1994). Mutational Analysis of the NH2-Terminal Glycosylation Sites of the Insulin Receptor α-subunit. Diabetes. 43(2). 240–246. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026